Answers are grounded in this paper and cite their sources.
Recently, senescent T cells in the peripheral blood have been detected using senescence-associated β-galactosidase (SA-βGal) activity and have been used as an endpoint in clinical trials. However, the epidemiological association between the abundance of SA-βGal-stained senescent CD8+ T cells and chronological age has not been fully elucidated. To examine the correlation between the proportion of SA-βGalhigh CD8+ T cells and age, we analyzed previously collected clinical trial data. We conducted a cross-sectional analysis of 632 Japanese adults aged 40–59 years who participated in the screening phase of a clinical trial. To characterize senescent CD8+ T cells, we measured the proportion of SA-βGalhigh in total CD8+ T cells and each subset—naïve, central memory (TCM), effector memory (TEM), and terminally differentiated effector memory (TEMRA). We then calculated the correlation coefficients between the proportion of SA-βGalhigh CD8+ T cells and age. The proportion of SA-βGalhigh cells in total CD8+ T cells, naïve, TCM, TEM, and TEMRA CD8+ T cells increased significantly with age. In Japanese adults, the proportion of SA-βGalhigh in CD8+ T cells may serve as a useful biomarker of immune senescence.
No takes yet. Share an insight, caveat, or question.
Tsubokawa et al. (2025) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: